ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test sale cost 4400 AED
COL6A6 Gene Myopathy COL6A6 Related Genetic Test sale cost 4400 AED COL6A6 Gene Myopathy COL6A6 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CROCC Gene Neurodevelopmental Disorder CROCC Related Genetic Test sale cost 4400 AED CROCC Gene Neurodevelopmental Disorder CROCC Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ACTA1 gene is crucial for encoding actin, a protein that plays a vital role in muscle contraction and structure. Mutations in the ACTA1 gene are associated with Nemaline Myopathy Type 3, a genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle fibers, visible under a microscope. This condition is part of a spectrum of neuromuscular disorders that can vary in severity and onset, often presenting challenges in movement and respiratory function.

To diagnose this specific form of myopathy, genetic testing is available at DNA Labs UAE, focusing on identifying mutations within the ACTA1 gene. The test is an essential tool for confirming the diagnosis, understanding the disease’s progression, and assisting in managing and planning treatment options. It involves analyzing the patient’s DNA to pinpoint mutations in the ACTA1 gene that are known to cause Nemaline Myopathy Type 3.

The cost of the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to accurately identify the genetic alterations responsible for the condition. Given the complexity of genetic testing and the expertise required, the cost reflects the resources and technology utilized to provide a definitive diagnosis. This test is a critical step for affected individuals and their families to gain a clear understanding of the condition and to navigate the challenges associated with Nemaline Myopathy Type 3.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test

At DNA Labs UAE, we offer the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test. This test is designed to identify potential mutations or variations in the ACTA1 gene associated with nemaline myopathy type 3, a rare genetic disorder characterized by muscle weakness and low muscle tone (hypotonia).

Test Components and Price

  • Components: ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test
  • Price: 4400.0 AED

Sample Condition and Report Delivery

  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks

Method and Test Type

  • Method: NGS Technology (Next-Generation Sequencing)
  • Test Type: Neurological Disorders

Doctor and Test Department

  • Doctor: Neurologist
  • Test Department: Genetics

Pre-Test Information

Prior to undergoing the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by ACTA1 Gene Nemaline Myopathy Type 3.

About the Test

The ACTA1 gene is associated with nemaline myopathy type 3. Next-generation sequencing (NGS) technology is utilized to analyze multiple genes simultaneously and identify genetic variations or mutations. The NGS genetic test for nemaline myopathy type 3 involves sequencing the ACTA1 gene to detect potential mutations or variations that may be causing the disorder. This test aids in confirming a diagnosis and understanding the underlying genetic cause of the condition.

Genetic testing is beneficial for individuals displaying symptoms suggestive of nemaline myopathy type 3, as well as their family members who may be at risk of carrying the same genetic mutation. It provides crucial information for healthcare providers to develop appropriate treatment plans and genetic counseling for affected individuals and their families.

Test Name ACTA1 Gene Nemaline myopathy type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ACTA1 Gene Nemaline myopathy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ACTA1 Gene Nemaline myopathy type 3
Test Details

The ACTA1 gene is associated with nemaline myopathy type 3, which is a rare genetic disorder characterized by muscle weakness and low muscle tone (hypotonia). NGS stands for next-generation sequencing, which is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations.

An NGS genetic test for nemaline myopathy type 3 would involve sequencing the ACTA1 gene to identify any potential mutations or variations that may be causing the disorder. This can help in confirming a diagnosis and understanding the underlying genetic cause of the condition.

Genetic testing can be useful for individuals with symptoms suggestive of nemaline myopathy type 3, as well as for their family members who may be at risk of carrying the same genetic mutation. It can provide important information for healthcare providers to develop appropriate treatment plans and genetic counseling for affected individuals and their families.

SKU: TEST-1821 Category:

Related products